 |
|
|
| |
Simplification of PI + RTV + FTC/TDF to Elvitegravir/C/F/TDF Maintains HIV Suppression and is Well-Tolerated
|
| |
| |
Reported by Jules Levin
CROI 2014 March 3-6 Boston, MA
J Arribas,1 G Pialoux,2 J Gathe,3 G Di Perri,4 J Reynes,5 P Tebas,6 T Nguyen,7 R Ebrahimi,7 K White,7 and D Piontkowsky7
1Hospital Universitario La Paz, Madrid, Spain; 2UPMC, Hopital Tenon APHP, Paris, France; 3Baylor College of Medicine, Houston, TX, USA; 4University of Torino, School of Medicine, Torino, Italy; 5Hopital Gui de Chauliac, Montpellier, France; 6University of Pennsylvania, Philadelphia, PA, USA; 7Gilead Sciences, Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
